King Pharmaceuticals | Evaluate

October 23, 2012

Pfizer’s next wave should cause ripples of concern

August 09, 2012

Vantage Point – Political backing unlikely to help developers of tamper-resistant painkillers

June 28, 2011

Pfizer spending a little on Icagen in hope of winning big

June 24, 2011

Painful damage as Remoxy is rejected again

June 21, 2011

Oxecta FDA approval tempered by lack of abuse resistance claim

May 17, 2011

Event - Acura and Pain hoping luck will change

February 04, 2011

Event - Takeda's ARB may be approvable but commercial potential uncertain

January 04, 2011

Clinical and regulatory events over the Christmas period

November 23, 2010

Pfizer highlights rare organic candidate amid M&A driven growth strategy

October 12, 2010

Pfizer is not paying a ransom for King

April 23, 2010

Acura’s blushes cause it to lose adcom backing

Load More